// App-Quantinova.ai

OC16.01 : The role of human chorionic gonadotrophin and transvaginal ultrasound in pregnancies of unknown location beyond 48 hours

Researchers

Presenter

  • C. Kyriacou

Principal Investigators

  • S. Bobdiwala

  • I. Elkington

  • J. Farren

  • N. Mitchell-Jones

  • F. Ayim

  • B. Chohan

  • S. Guha

  • E. Kirk

  • O. Abughazza

  • M. Al-Memar

  • V. Vathanan

  • D. Gould

  • C. Stalder

  • D. Timmerman

  • T. Bourne

Medical Centers

  • Tommy's National Centre for Miscarriage Research, Queen Charlotte's and Chelsea Hospital, Imperial College, London, United Kingdom

  • Guy's Hospital, London, United Kingdom

  • Chelsea and Westminster Hospital, London, United Kingdom

  • Whittington Hospital, London, United Kingdom

  • Wexham Park Hospital, Slough, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Royal Surrey County Hospital, Guildford, United Kingdom

  • Urology, Department of Development and Regeneration, University Hospitals Leuven, Leuven, Belgium

  • Department of Obstetrics and Gynecology, University Hospital Leuven, Kuleuven, Belgium

Locations

  • United Kingdom

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

Disease

  • Ectopic pregnancy

Biomarkers

  • Chorionic Gonadotropin Subunit Beta 5

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved